ask="N/A"
ask_size="N/A"
average_daily_volume="42829"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="+0.04"
change_from_200_day_moving_average="-1.52"
change_from_50_day_moving_average="-3.67"
change_from_52_week_high="-8.59"
change_From_52_week_low="7.75"
change_in_percent="+0.23%"
close="17.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6898000"
high="18.14"
high_52_weeks="26.36"
last_trade_date="1/23/2017"
last_trade_price="17.77"
last_trade_size="1215"
last_trade_time="4:00pm"
low="17.19"
low_52_weeks="10.02"
market_capitalization="297.01M"
moving_average_200_day="19.29"
moving_average_50_day="21.44"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="17.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.87%"
percent_change_from_50_day_moving_average="-17.12%"
percent_change_from_52_week_high="-32.59%"
percent_change_from_52_week_low="+77.35%"
previous_close="17.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.04"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.09"
stock_exchange="NGM"
symbol="PTGX"
volume="33043"
weeks_range_52="10.02 - 26.36"
